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Abstract
Background: Parturition at term and preterm is characterized by sterile inflammatory processes occurring in the
absence of infection whereby peripheral leukocytes infiltrate gestational tissues in response to chemotactic signals.
In response to a homing signal, recruited leukocytes undergo diapedesis and extravasate through capillaries,
migrating into stromal tissue. There they interact with resident immune and stromal cells to produce a mixture
of matrix metalloproteinases, prostaglandins and cytokines including interleukin-1β (IL-1β) and IL-6 that in turn
transform the uterus from pregnancy to parturition. Since migration is an early parturitional event our purpose
was to study the migration of maternal peripheral blood leukocytes in response to a standard chemotactic
signal during several different conditions of late pregnancy.
Methods: We used a cross-sectional observational study design. Subjects were (sTL) spontaneous normal
labour delivered vaginally at term, (TNL) elective caesarean section at term without labour, (PTL) preterm in
labour, (PTNL) preterm not in labour, (TPTL) threatened preterm labour, and (pPROM) preterm with premature rupture
of membranes. Leukocytes (100,000) obtained by venipuncture and chemotactic factor isolated from term labour fetal
membranes were placed in the upper and lower halves, respectively, of a Boyden chamber separated by a filter with
3μm pores. Migrated leukocytes were assessed by flow cytometry. The number of leukocytes that migrated in 90 min
was the primary outcome measure.
Results: Increased numbers of leukocytes from peripheral blood of women in labour (TL or PTL) or soon to go into
labour (PPROM) migrated towards a chemotactic signal than did leukocytes from women not in labour (TNL,
PTNL, or TPTL) (p < 0.0001). All pPROM delivered within 7d; TPTL delivered >30d. Receiver operating characteristic curve
parameters indicated the cut-off point for delivery within 7d to be 37,082 leukocytes with sensitivity 78.1%, specificity
88.9%, positive predictive value 91.4%, negative predictive value 72.7%, and area under the curve 0.83.
Conclusion: Leukocyte migration to a fetal membrane signal varies in a predictable fashion during various clinical
situations of late gestation. This principle has the potential to be improved to become a clinical test to predict
delivery.
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Background
Parturition at term and preterm is characterized by sterile
inflammatory processes occurring in the absence of infec-
tion whereby peripheral leukocytes infiltrate gestational tis-
sues in response to chemotactic signals [1–10]. In response
to a homing signal, recruited leukocytes undergo diapedesis
and extravasate through capillaries into stromal tissue [11].
Then together with resident immune and stromal cells,
they produce a mixture of matrix metalloproteinases
(MMPs) and cytokines including interleukin-1β (IL-1β)
and IL-6 that in turn transform the uterus from pregnancy
to parturition by producing prostaglandins, additional
MMPs, cytokines, chemokines and uterine transformation
proteins [12, 13]. The result is a positive feedback amplifi-
cation cascade culminating in parturition.
We demonstrated in rats and guinea pigs that the uterus
or chorio-amnion produce increasing concentrations of
chemotactic factor in late gestation, and there is an in-
crease in leukocyte responsiveness to this factor [14, 15].
Full thickness fetal membranes (amnion, chorion, decidua
vera) isolated from spontaneous term labour (TL) patients
also is a significant source of chemoattractant of term
leukocytes in biological assays [9, 10] and the chemoat-
tractive potency of TL fetal membrane extract is greater
than extract obtained from term not in labour patients
(TNL). Thus, labour is characterized by two concurrent
events: increases in the chemoattractant produced by
fetal membrane tissues and, as we demonstrated in rats,
an increase in peripheral leukocyte responsiveness (as
defined by migration) in response to term chemotactic
factor [14]. However, there are no data on whether human
peripheral leukocyte migration responsiveness to human
TL chemotactic extract increases in late gestation or has
characteristics that are consistent with various late preg-
nancy clinical conditions. Therefore, we hypothesized that
human peripheral leukocyte responsiveness to a term
chemotactic signal increases as gestation progresses
toward the onset of labour at both term and preterm.
Methods
Clinical study groups
Pregnant women were recruited from the Royal Alexandra
Hospital in Edmonton, Alberta with informed, written
consent prior to inclusion in the study. Specific inclusion
criteria were used to place women into six study groups
for blood sampling: sTL (spontaneous normal labour
delivered vaginally at term, 37–42 wk, n = 24), TNL
(elective caesarean section at term without labour, n = 16),
PTL (preterm in labour, 22–36 wk, n = 10), PTNL (normal
women sampled preterm but not in labour, 22–36 wk,
n = 16), TPTL (threatened preterm labour as identified
by uterine contractions or cervical dilation, 22–36 wk,
n = 11) and pPROM (preterm with premature rupture
of membranes but without contractions or dilated
cervix, 22–36 wk, n = 8). Patients who had disease or
medication, multiple pregnancy, fetal congenital dis-
ease, and clinical signs of infection (body temperature
over 38 °C) were excluded from this study.
Chemotactic factor isolation
The extracted chemoattractant was used in the migration
assay. Fetal membranes were collected from fifteen women
who underwent term spontaneous labour without compli-
cations. Exclusion criteria were the same as for leukocyte
collection. The preparation of the chemoattractant was as
published with minor modifications [9, 10, 14, 15]. From
each of the fifteen sets of fetal membranes a 4cm square
piece was cut. Each of these fifteen square pieces were then
washed with 1× phosphate buffered saline (PBS) for 3
times to remove blood and debris, and homogenized with
4mL of Dulbecco’s Modified Eagle’s Medium (DMEM)
(Thermo Fischer Scientific Inc., Ottawa, ON, Canada).
Peptidase inhibitors were omitted as tests including
them demonstrated they had no effect upon the chemoat-
traction potential of the final preparation. Following centri-
fugation at 3,000 × g for 30 min at 4 °C and then 20,000 × g
for 2 h at 4 °C (Thermo Scientific™ Sorvall™ ST 16R,
Thermo Fischer Scientific Inc., Ottawa, ON, Canada),the
supernatants from each piece were collected and pooled
together. Protein concentrations (BCA method) were
adjusted to 4μg/μL with DMEM. Pooled chemoattractant
extracts were aliquoted and stored at−80 °C. For each ex-
periment a vial(s) was placed on ice to thaw. All experi-
ments in this study used vials prepared and frozen from the
same batch of chemoattractant and were performed within
one year of the original preparation. There was no change
in the activity of chemoattractant in that time and the
chemoattractant performed similarly to batches prepared at
other times (data not shown).
Blood sampling and leukocyte isolation
Leukocytes were prepared as published with minor
modifications [9, 10]. Peripheral blood samples were
collected by venipuncture upon recruitment into the
study and granting of consent using a standardized
protocol for each subject in each of the groups. Leuko-
cytes present in peripheral maternal blood samples drawn
into 6mL heparinized tubes were isolated and used in the
LMA. Five mL of the anticoagulated blood were combined
with 1mL HetaSep (Stemcell, Vancouver, BC, Canada) to
remove erythrocytes through sedimentation. Samples were
placed in a humidified incubator at 37 °C for 10 min to
allow sedimentation of erythrocytes. Approximately 3mL
of the top, leukocyte-rich plasma layer were collected and
washed with four-fold of 1× PBS. Leukocytes were sedi-
mented using gentle centrifugation (120 × g for 10 min at
20 °C without the brake). The supernatant was discarded
and leukocytes resuspended in 4mL Hyclone™ Roswell
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Park Memorial Institute 1640 medium (RPMI) (Thermo
Fischer Scientific Inc., Ottawa, ON, Canada) containing
2.0mM L-glutamine. A Bright Line™ hemacytometer
(Sigma-Aldrich, St. Louis, MO, USA) was used to count
leukocytes. The number of dead leukocytes were
recorded using Trypan blue method and the suspension
mixture was only used with a viability rate >95%. The
leukocyte suspension was diluted using RPMI to a final
concentration of 1x105 cells/50μL and used in the
LMA within an hour of isolation.
Leukocyte migration assay (LMA)
The procedure used was published [9, 10, 14, 15] with
recent modifications to improve the assay performance.
Modified Boyden chemotaxis chambers (AP48; Neuro
Probe, Gaithersburg, MD, USA) were used in the assay.
Twenty-five μL of the chemoattractant extract (100μg
total protein) or DMEM as negative control were placed
in the lower chamber to create a slightly positive meniscus.
A polycarbonate membrane with 3μm pores (Neuro Probe,
Gaithersburg, MD, USA) was next placed over the lower
chamber followed by a rubber gasket and then the upper
chamber. Previously we used a filter with 5μm pores, but
we found it allowed too many leukocytes through in the
control (blank) tubes resulting in high background counts.
We thoroughly tested the system performance with the
smaller pores and consequent low blanks (ca. 50–100 cells)
and found that the number of cells that migrated was dir-
ectly dependent upon the amount of chemoattractant
placed in the lower chamber and was directly proportional
to the number of cells placed in the upper chamber (Fig. 1).
Fifty μL of suspension containing 100,000 leukocytes
was pipetted into each well of the upper chamber. The
chamber was incubated in a humidified atmosphere at
37 °C containing 5% CO2 for 90 min. Following incuba-
tion, the upper chamber liquid was removed and the
lower chamber samples (into which leukocytes migrated)
were individually collected in BD Falcon™ 5mL polystyr-
ene round bottom tubes (Thermo Fischer Scientific Inc.,
Ottawa, ON, Canada) and combined with 300μL
OptiLyse (Beckman Coulter, Mississauga, ON, Canada)
to lyse red blood cells and fixed leukocytes. For the sub-
sets analysis, antibodies were added to the tube before
adding OptiLyse. Samples were incubated in the dark for
15 min and 1mL 1× PBS was added to each tube. Fol-
lowing centrifugation at 1,000 × g for 10 min at 4 °C, the
supernatant was discarded and 475μL 1× PBS with 1%
formalin was added to fix leukocytes. Lower chamber
samples were then kept covered in a 4 °C cold room
until quantification using flow cytometry (BD
FACSCanto™ II, BD Biosciences, San Jose, CA, USA).
Flow cytometry
Flow cytometry was used to quantify the number of
leukocytes that migrated from the upper chamber down
into the lower chamber through the polycarbonate
membrane. Each sample had 25μl of CountBright™
Absolute Counting Beads (Life Technologies, Burling-
ton, ON, Canada) added prior to analysis using flow cy-
tometry. The flow cytometer was set to analyze the
samples for 30 sec and data were collected using BD
FACSDiva software (BD Biosciences, San Jose, CA, USA).
Leukocytes were gated based on their forward and side
scatter. The total number of leukocytes migrated was
calculated using the number of beads added to the tube
multiplied by the ratio of leukocytes to beads in the
sample aliquot taken by the flow cytometer. The
number of leukocytes that migrated in the blank, or
negative control, wells containing DMEM was
subtracted from all samples in the final calculations.
Leukocyte subtypes that migrated were also analyzed
using flow cytometry in a few test cases. Multitest 6-color
TBNK Reagent and V450 Mouse Anti-Human CD14 (BD
Bioscience, CA, USA) were used for staining cells.
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Fig. 1 Leukocyte migration assay performance characteristics. a Migration as a function of amount of chemoattractant placed in the lower
chamber. Increasing amounts of homogenate (determined as total protein in μg) were placed in the lower chamber and migrated (attracted)
cells counted after performing the assay as in Methods. Different superscripts denote statistical significance, p < 0.05. b. Migration as a function of
number of leukocytes placed in the upper chamber. Increasing numbers of cells were placed in the upper chamber and migrated (attracted) cells
counted after performing the assay as in Methods. Different superscripts denote statistical significance, p < 0.05
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Granulocytes were considered as CD45+ CD3− CD19−
CD16/56− CD14−cells.
Statistics
Data were analyzed and graphs were drawn with GraphPad
Prism Version 5.0 software (GraphPad Prism Software, CA,
USA). Data were tested for normal distribution and then
significance testing was performed with an unpaired t test
for two-group comparison. One-way ANOVA followed by
Tukey’s multiple comparison post hoc test was used to
detect statistically significant differences between the study
groups of over two. P < 0.05 was accepted as significant.
Results
The clinical characteristics of the subjects are described
in Table 1. There were no significant differences between
the groups of pregnant women with respect to maternal
age and parity. Mean gestational age at delivery was
significantly higher (p < 0.05) in subjects <37 weeks
gestation experiencing uterine contractions or cervical
ripening (TPTL) or those who were PTNL than when
they were tested for leukocyte migration. In each of
these groups women delivered more than 30d later.
Subjects in the pPROM group all delivered within 7
days of testing leukocyte migration.
The linearity of leukocyte migration as a function of
amount of chemoattractant protein placed in the lower
chamber or number of cells placed in the upper chamber is
described in Fig. 1. The assay performance was consistent
and proportional.
Leukocyte responsiveness to term chemotactic signal
was analyzed in leukocytes from fifty-four women with
normal uncomplicated pregnancies not in labour and <37
weeks gestational age (PTNL), those at term but not in
labour (TNL) and those in spontaneous TL (sTL) (Fig. 2a).
The data indicated that more sTL leukocytes migrated
than PTNL or TNL leukocytes (p < 0.01). When the data
of Fig. 2a are replotted testing gestational age against
leukocyte migration, a sharp upward trend is evident in
TNL and sTL women (Pearson’s correlation coefficient on
log10 transformed data, r (54) = 0.306, p = 0.025).
We collected leukocytes from healthy subjects in three
different not in labour groups at <37 weeks gestation:
PTNL, TPTL and pPROM, and compared to women in
preterm labour (PTL) and sTL (Fig. 2c). Leukocyte mi-
gration was similarly high in the sTL and PTL groups
and both were significantly greater (p < 0.0001) than the
TPTL and PTNL groups. The pPROM group was
significantly higher than the PTNL group (p < 0.0001),
but there was no significant difference between the
pPROM and PTL and sTL groups.
Using flow cytometry to analyze the leukocyte subtypes,
we determined the highest population of migrated leuko-
cytes was granulocytes in PTNL, PTL, and TL groups and
there was a significant difference (p < 0.05) in neutrophil
migration between PTNL and PTL +TL groups. There was
no significant difference found between the groups in terms
of subtypes migrated (Fig. 2d). These results informed that
assessing the total number of leukocytes migrated provided
a reasonable estimate of leukocyte attraction to the
standard chemotactic signal.
Using all the data from Fig. 2b and delivery within 7
days as the comparator, we examined the parameters of
this migration assay by receiver-operating characteristic
curve. It identified the cut-off point of delivery within 7
days at 37,082 leukocytes with 78.1% sensitivity, 88.9%
specificity, 91.4% positive predictive value, 72.7% nega-




This is the first report demonstrating that maternal
human peripheral leukocytes increase their migration
toward a term fetal membrane chemotactic signal when in
labour at term or preterm or in the early stages of labour
such as pPROM. The exciting aspect of this migration assay
is that it has the potential to differentiate those subjects
who will not deliver for several weeks from those subjects
experiencing symptoms who will deliver within a week.
The percentages of various leukocytes that migrated in
the Boyden chamber to the chemotactic signal vary
from their distribution when collected and placed into
the upper chamber; more neutrophils appear to be
more sensitive in labouring women. This suggests that
the migrated leukocytes, especially neutrophils, developed
Table 1 Clinical characteristics of the subjects
TNL sTL PTNL TPTL pPROM PTL
Number 16 24 16 11 8 10
Age 29.0 ± 5.1 28.8 ± 6.4 28.4 ± 5.9 29.3 ± 6.5 26.1 ± 4.4 30.4 ± 4.6
Parity 1.8 ± 1.3 1.5 ± 1.6 1.8 ± 2.0 1.5 ± 1.6 1.9 ± 1.2 1.2 ± 0.9
GA at sampling 39.5 ± 1.1 39.2 ± 1.2 31.9 ± 3.8 29.4 ± 4.0 31.5 ± 2.6 31.8 ± 3.9
GA at delivery 37.1 ± 4.3* 37.5 ± 2.4** 31.7 ± 3.4
(Mean ± SEM), GA = gestational age (wk)
*p < 0.002, **p < 0.0005 vs. GA at sampling (Unpaired t test)
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greater responsiveness to the chemotactic substance in
human fetal membranes than other cells. This would be
consistent with reports that demonstrated higher per-
centages of neutrophils than were in peripheral blood
in late gestation or that invaded gestational tissues at
term labour [1–3, 16, 17]. However those studies also
report increasing invasion of monocytes, suggesting
that migration and invasion may be differentially regu-
lated. Thus it is important to note that this assay
assesses just one aspect of the more complex process of
leukocyte invasion of the uterus prior to delivery.
The increasing responsiveness of the leukocytes to the
chemoattractant with labour onset suggests that either
there are more leukocyte receptors to the chemoattractant,
better coupling of receptors with intracellular signal trans-
duction mechanisms and/or an upregulation of the migra-
tion apparatus in the cells. In future investigation we intend
to determine whether studying migration of neutrophils
only will improve the parameters of the study. At present,
though, it is clear that total leukocyte migration is an effect-
ive outcome measure for assessing proximity to delivery.
We did not assess the chemical nature of the chemo-
attractant present in the crude homogenates of human fetal
membranes. Data (not shown) indicates it is also present in
uterine tissues from mice and rats and these rodent
chemoattractants are able to attract human leukocytes.
We are in the process of identifying it chemically with
expert collaborators. Preliminary analysis suggests it is
not one of the common chemokines and isolating it
has proven difficult. We will continue our analysis
using a variety of biochemical isolation techniques.

































































































Fig. 2 Leukocyte migration in various gestational and clinical groups and leukocyte subtypes migrated. a, b. Cell migrations from various normal
gestational groups, PTNL, TNL and TL (Methods and Table 1). A: cell migrations from individual subjects in groups PTNL vs. TNL vs. sTL. Different
superscripts denote statistical difference, p < 0.01, one-way ANOVA with Tukey’s post hoc test. B: cell migrations from PTNL, TNL and sTL individual
subject values. Pearson’s correlation coefficient on log10 transformed data, r (54) = 0.306, p = 0.025. c. Cell migrations from various clinical groups,
PTNL vs. TPTL vs. pPROM vs. PTL vs. sTL. Different superscripts denote statistical difference, p < 0.0001, one-way ANOVA with Tukey’s post hoc test.
d. Various leukocyte classes (granulocytes (CD45+ CD3− CD19− CD16/56− CD14−cells), T-lymphocytes (CD3−), NK cells (CD16/56), B-lymphocytes
(CD19), monocytes (CD14)) migrated in PTNL (n = 4, open bars) and sTL + PTL (n = 4, closed bars). The majority were granulocytes. *p < 0.003















Fig. 3 Receiver-operating characteristic curve of leukocyte migration assay
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Considerable more work is required before it will be
identified.
The receiver-operating characteristic curve utilized all
the data available (Fig. 3) to determine preliminary
parameters of the assay. While preliminary, these data
are highly encouraging in that the positive predictive
value, negative predictive value, sensitivity and specificity
are very high. They suggest that with further improvement
in terms of simplifying the technical aspects so it can
become a point of care test, the assay described here
may form the basis for a future clinical diagnostic test.
Strengths and limitations
We demonstrated an interesting and potentially clinically
applicable characteristic of circulating leukocytes in late
gestation women and those in various clinical situations.
Further refinement and improvement will both reveal
basic biological mechanisms of late gestation in normal
and inflammatory situations plus possibly lead to an
informative diagnostic test to predict preterm birth
risk. One limitation of this study is that it is only cross-
sectional with separate subjects in each determination.
Future work comprising longitudinal samples from a
single subject during pregnancy, at term or preterm,
threatened preterm or ruptured membranes would be
very informative.
Interpretation
Leukocyte migration has the potential with further
development, refinement and simplification to become a
diagnostic test that would be valuable for identifying
asymptomatic women who may be at risk for preterm birth.
In addition, many symptomatic women present with signs
of preterm labor but only 10–20% will deliver preterm. It is
important from a treatment and also a health care costing
perspective to know which of these women to treat or
admit to hospital, and which to send home. Existing tests,
the fetal fibronectin (fFN) test and the insulin-like growth
factor binding protein-1 (IGFBP-1) test, have high negative
prediction values, but low positive predictive values
[17–19]. They indicate who will not deliver, but they
do not indicate who will deliver within one to two
weeks. A test with a high positive predictive value,
along with a reasonable negative predictive value,
would be a significant advance in the management of
pregnant women.
Conclusion
Leukocyte migration to a fetal membrane signal varies in
a predictable fashion during various clinical situations of
late gestation. This principle has the potential to be
improved to become a clinical test to predict delivery.
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